Boston Scientific Corp
NYSE:BSX

Watchlist Manager
Boston Scientific Corp Logo
Boston Scientific Corp
NYSE:BSX
Watchlist
Price: 91.07 USD 1.35% Market Closed
Market Cap: 134.2B USD
Have any thoughts about
Boston Scientific Corp?
Write Note

Balance Sheet

Balance Sheet Decomposition
Boston Scientific Corp

Current Assets 8.8B
Cash & Short-Term Investments 2.5B
Receivables 2.5B
Other Current Assets 3.8B
Non-Current Assets 29.3B
Long-Term Investments 532m
PP&E 3.5B
Intangibles 20.8B
Other Non-Current Assets 4.5B
Current Liabilities 5.9B
Accounts Payable 907m
Accrued Liabilities 2.3B
Other Current Liabilities 2.7B
Non-Current Liabilities 11.5B
Long-Term Debt 9.2B
Other Non-Current Liabilities 2.2B

Balance Sheet
Boston Scientific Corp

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
587
319
196
188
146
217
1 734
1 925
928
865
Cash Equivalents
587
319
196
188
146
217
1 734
1 925
928
865
Total Receivables
1 183
1 275
1 472
1 548
1 608
1 828
1 531
1 778
1 970
2 228
Accounts Receivables
1 183
1 275
1 472
1 548
1 608
1 828
1 531
1 778
1 970
2 228
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
946
1 016
955
1 078
1 166
1 579
1 351
1 610
1 867
2 484
Other Current Assets
890
861
616
1 008
1 083
1 075
2 078
1 004
995
937
Total Current Assets
3 606
3 471
3 239
3 822
4 003
4 699
6 694
6 317
5 760
6 514
PP&E Net
1 507
1 490
1 630
1 697
1 782
2 415
2 542
2 687
2 832
3 298
PP&E Gross
1 507
1 490
1 630
1 697
1 782
2 415
2 542
2 687
2 832
3 298
Accumulated Depreciation
2 339
2 572
2 735
2 928
2 958
3 089
3 224
3 273
3 282
3 484
Intangible Assets
5 606
6 194
5 883
5 837
6 372
7 886
5 917
6 121
5 902
6 003
Goodwill
5 898
6 473
6 678
6 998
7 911
10 176
9 951
11 988
12 920
14 387
Long-Term Investments
0
0
0
0
0
0
918
412
407
413
Other Long-Term Assets
407
505
666
688
931
5 389
4 755
4 704
4 648
4 521
Other Assets
5 898
6 473
6 678
6 998
7 911
10 176
9 951
11 988
12 920
14 387
Total Assets
17 024
N/A
18 133
+7%
18 096
0%
19 042
+5%
20 999
+10%
30 565
+46%
30 777
+1%
32 229
+5%
32 469
+1%
35 136
+8%
Liabilities
Accounts Payable
262
209
447
530
349
542
513
794
862
942
Accrued Liabilities
1 256
1 197
1 250
1 280
1 534
1 706
1 762
2 243
1 990
2 516
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
403
3
64
1 801
2 253
1 416
13
261
20
531
Other Current Liabilities
925
1 021
1 826
2 043
1 124
1 202
1 393
976
931
944
Total Current Liabilities
2 846
2 430
3 587
5 654
5 260
4 866
3 681
4 274
3 803
4 933
Long-Term Debt
3 841
5 674
5 420
3 815
4 803
8 592
9 130
8 804
8 915
8 571
Deferred Income Tax
1 214
735
18
191
328
595
330
310
144
134
Minority Interest
0
0
0
0
0
0
0
0
0
248
Other Liabilities
2 666
2 974
2 338
2 370
1 882
2 635
2 310
2 219
2 034
1 968
Total Liabilities
10 567
N/A
11 813
+12%
11 363
-4%
12 030
+6%
12 273
+2%
16 688
+36%
15 451
-7%
15 607
+1%
14 896
-5%
15 854
+6%
Equity
Common Stock
16
16
16
16
16
16
17
17
17
17
Retained Earnings
8 689
8 927
8 581
8 390
6 953
2 253
2 378
1 392
750
819
Additional Paid In Capital
16 703
16 860
17 014
17 161
17 346
17 561
19 732
19 986
20 289
20 647
Unrealized Security Profit/Loss
0
0
6
1
0
0
0
0
0
0
Treasury Stock
1 717
1 717
1 717
1 717
1 717
1 717
2 251
2 251
2 251
2 251
Other Equity
144
88
7
57
34
270
206
262
268
50
Total Equity
6 457
N/A
6 320
-2%
6 733
+7%
7 012
+4%
8 726
+24%
13 877
+59%
15 326
+10%
16 622
+8%
17 573
+6%
19 282
+10%
Total Liabilities & Equity
17 024
N/A
18 133
+7%
18 096
0%
19 042
+5%
20 999
+10%
30 565
+46%
30 777
+1%
32 229
+5%
32 469
+1%
35 136
+8%
Shares Outstanding
Common Shares Outstanding
1 327
1 347
1 362
1 373
1 385
1 395
1 417
1 426
1 433
1 466

See Also

Discover More